As a negative regulator of PAK1 (p21-activated protein kinase 1), CRIPAK is hormone sensitive and was shown to have deleterious mutations in squamous cell- and adenocarcinoma [21] and was further confirmed in other cancer types (COSMIC: COSG57208). Here, PAK1 is linked to adenocarcinoma.